Clinical Trial Results:
A multicentre, randomised study comparing the starting treatment with full dose or dose escalation of nevirapine in patients needing efavirenz withdrawal due to adverse reactions. Estudio multicéntrico aleatorizado para comparar el inicio del tratamiento con Neviparina a dosis plenas o a dosis escaladas en pacientes que precisan la retirada de Efavirenz por reacciones adversas
Summary
|
|
EudraCT number |
2006-001208-35 |
Trial protocol |
ES |
Global completion date |
07 Sep 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
27 Nov 2021
|
First version publication date |
27 Nov 2021
|
Other versions |
|
Summary report(s) |
GESIDA |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.